BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36867310)

  • 1. Incidence of bloodstream infections due to multidrug-resistant pathogens in ordinary wards and intensive care units before and during the COVID-19 pandemic: a real-life, retrospective observational study.
    Segala FV; Pafundi PC; Masciocchi C; Fiori B; Taddei E; Antenucci L; De Angelis G; Guerriero S; Pastorino R; Damiani A; Posteraro B; Sanguinetti M; De Pascale G; Fantoni M; Murri R
    Infection; 2023 Aug; 51(4):1061-1069. PubMed ID: 36867310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood culture utilization and epidemiology of antimicrobial-resistant bloodstream infections before and during the COVID-19 pandemic in the Indonesian national referral hospital.
    Sinto R; Lie KC; Setiati S; Suwarto S; Nelwan EJ; Djumaryo DH; Karyanti MR; Prayitno A; Sumariyono S; Moore CE; Hamers RL; Day NPJ; Limmathurotsakul D
    Antimicrob Resist Infect Control; 2022 May; 11(1):73. PubMed ID: 35590391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the COVID-19 pandemic on the incidence of multidrug-resistant bacterial infections in an acute care hospital in Brazil.
    Polly M; de Almeida BL; Lennon RP; Cortês MF; Costa SF; Guimarães T
    Am J Infect Control; 2022 Jan; 50(1):32-38. PubMed ID: 34562526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of coronavirus disease 2019 (COVID-19) on antimicrobial resistance among major pathogens causing healthcare-associated infection.
    Chang HC; Chang CH; Tien KL; Tai CH; Lin LM; Lee TF; Ku SC; Fang CT; Chen YC; Sheng WH
    J Formos Med Assoc; 2024 Jan; 123(1):123-132. PubMed ID: 37451958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collateral impacts of pandemic COVID-19 drive the nosocomial spread of antibiotic resistance: A modelling study.
    Smith DRM; Shirreff G; Temime L; Opatowski L
    PLoS Med; 2023 Jun; 20(6):e1004240. PubMed ID: 37276186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections.
    Gaspari R; Spinazzola G; Teofili L; Avolio AW; Fiori B; Maresca GM; Spanu T; Nicolotti N; De Pascale G; Antonelli M
    Eur J Clin Invest; 2021 Dec; 51(12):e13687. PubMed ID: 34599600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interface between COVID-19 and bacterial healthcare-associated infections.
    O'Toole RF
    Clin Microbiol Infect; 2021 Dec; 27(12):1772-1776. PubMed ID: 34111586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of bacterial agents isolated from endotracheal aspirate cultures of Covid-19 general intensive care patients and their antibiotic resistance profiles compared to pre-pandemic conditions.
    Bahçe YG; Acer Ö; Özüdoğru O
    Microb Pathog; 2022 Mar; 164():105409. PubMed ID: 35041973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of Microbial Factors of Healthcare-Associated Infections Including Multidrug-Resistant Pathogens and Antibiotic Consumption at the University Intensive Care Unit in Poland in the Years 2011-2018.
    Litwin A; Fedorowicz O; Duszynska W
    Int J Environ Res Public Health; 2020 Sep; 17(19):. PubMed ID: 32977435
    [No Abstract]   [Full Text] [Related]  

  • 10. Gram-negative ESKAPE bacteria bloodstream infections in patients during the COVID-19 pandemic.
    Alcántar-Curiel MD; Huerta-Cedeño M; Jarillo-Quijada MD; Gayosso-Vázquez C; Fernández-Vázquez JL; Hernández-Medel ML; Zavala-Pineda M; Morales-Gil MÁ; Hernández-Guzmán VA; Bolaños-Hernández MI; Giono-Cerezo S; Santos-Preciado JI
    PeerJ; 2023; 11():e15007. PubMed ID: 37013147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative incidence of early and late bloodstream and respiratory tract co-infection in patients admitted to ICU with COVID-19 pneumonia versus Influenza A or B pneumonia versus no viral pneumonia: wales multicentre ICU cohort study.
    Pandey M; May A; Tan L; Hughes H; Jones JP; Harrison W; Bradburn S; Tyrrel S; Muthuswamy B; Berry N; Pugh R; Sutton D; Campbell A; Morgan M
    Crit Care; 2022 Jun; 26(1):158. PubMed ID: 35655224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology, time course, and risk factors for hospital-acquired bloodstream infections in a cohort of 14,884 patients before and during the COVID-19 pandemic.
    Taddei E; Pafundi PC; Masciocchi C; Fiori B; Segala FV; Antenucci L; Guerriero S; Pastorino R; Scarsi N; Damiani A; Sanguinetti M; De Pascale G; Fantoni M; Murri R; De Angelis G
    Infect Dis (Lond); 2023 Nov; 55(11):776-785. PubMed ID: 37750316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug-resistant organism bloodstream infection and hospital acquisition among inpatients in three tertiary Greek hospitals during the COVID-19 era.
    Karakosta P; Vourli S; Kousouli E; Meletis G; Tychala A; Louka C; Vasilakopoulou A; Protonotariou E; Mamali V; Zarkotou O; Skoura L; Pournaras S
    Eur J Clin Microbiol Infect Dis; 2024 Jun; 43(6):1241-1246. PubMed ID: 38530465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and outcomes of culture-positive bloodstream pathogens prior to and during the SARS-CoV-2 pandemic: a multicenter evaluation.
    Bauer KA; Puzniak LA; Yu KC; Finelli L; Moise P; Ai C; Watts JA; Gupta V
    BMC Infect Dis; 2022 Nov; 22(1):841. PubMed ID: 36368931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Literature review on the distribution characteristics and antimicrobial resistance of bacterial pathogens in neonatal sepsis.
    Wang J; Zhang H; Yan J; Zhang T
    J Matern Fetal Neonatal Med; 2022 Mar; 35(5):861-870. PubMed ID: 32102584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bloodstream infections and antimicrobial resistance patterns in a South African neonatal intensive care unit.
    Morkel G; Bekker A; Marais BJ; Kirsten G; van Wyk J; Dramowski A
    Paediatr Int Child Health; 2014 May; 34(2):108-14. PubMed ID: 24621234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007.
    Burton DC; Edwards JR; Horan TC; Jernigan JA; Fridkin SK
    JAMA; 2009 Feb; 301(7):727-36. PubMed ID: 19224749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory confirmed bloodstream infection aetiology in an intensive care unit: eight years study.
    Orsi GB; Franchi C; Marrone R; Giordano A; Rocco M; Venditti M
    Ann Ig; 2012; 24(4):269-78. PubMed ID: 22913170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance trends in bloodstream infections at a large teaching hospital in China: a 20-year surveillance study (1998-2017).
    Tian L; Zhang Z; Sun Z
    Antimicrob Resist Infect Control; 2019; 8():86. PubMed ID: 31161033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic Resistance Profile of Common Bacteria Isolated from Blood Stream, Lower Respiratory Tract and Urinary Infections in Intensive Care Unit in Saudi Arabia: A Retrospective Study.
    Kabrah AM; Kabrah SM; Bahwerth FS; Alredaini NF
    Ethiop J Health Sci; 2021 Nov; 31(6):1231-1240. PubMed ID: 35392341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.